Drug intelligence / Profile preview

tellurium

Development stage: Preclinical
Modality: Nanoparticles → Drug Delivery Systems
Administration: Oral, Sublingual, Topical, Inhalation

Overview

Tellurium (Te) is a rare element that has garnered interest for its biological effects, particularly its reported ability to reduce cholesterol content in vivo. Studies have explored the biosynthesis of tellurium nanoparticles (Te NPs) by microorganisms like *Lactobacillus plantarum*. These nanoparticles have been observed to significantly decrease serum cholesterol and triglyceride levels in animal models, suggesting a potential role in managing hypercholesterolemia and related conditions.

Beyond the preview

Go deeper on tellurium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tellurium.

Explore the full profile